BeyondSpring (BYSI) Competitors $1.50 +0.06 (+4.17%) As of 02:01 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BYSI vs. NBP, ALEC, KROS, ARCT, and FENCShould you buy BeyondSpring stock or one of its competitors? MarketBeat compares BeyondSpring with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with BeyondSpring include I-Mab (NBP), Alector (ALEC), Keros Therapeutics (KROS), Arcturus Therapeutics (ARCT), and Adherex Technologies (FENC). These companies are all part of the "pharmaceutical products" industry. BYSI vs. NBPBYSI vs. ALECBYSI vs. KROSBYSI vs. ARCTBYSI vs. FENCHow does BeyondSpring compare to I-Mab?BeyondSpring (NASDAQ:BYSI) and I-Mab (NASDAQ:NBP) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings. Do analysts rate BYSI or NBP? I-Mab has a consensus target price of $9.00, suggesting a potential upside of 407.04%. Given I-Mab's stronger consensus rating and higher probable upside, analysts plainly believe I-Mab is more favorable than BeyondSpring.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BeyondSpring 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00I-Mab 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media favor BYSI or NBP? In the previous week, BeyondSpring had 3 more articles in the media than I-Mab. MarketBeat recorded 4 mentions for BeyondSpring and 1 mentions for I-Mab. BeyondSpring's average media sentiment score of 0.72 beat I-Mab's score of 0.00 indicating that BeyondSpring is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BeyondSpring 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive I-Mab 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders and institutionals hold more shares of BYSI or NBP? 40.3% of BeyondSpring shares are owned by institutional investors. Comparatively, 38.4% of I-Mab shares are owned by institutional investors. 29.3% of BeyondSpring shares are owned by company insiders. Comparatively, 22.1% of I-Mab shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has better earnings & valuation, BYSI or NBP? BeyondSpring has higher earnings, but lower revenue than I-Mab. BeyondSpring is trading at a lower price-to-earnings ratio than I-Mab, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeyondSpring$1.75M35.25-$1.01M-$0.14N/AI-Mab$3.89M52.77-$46.27M-$0.36N/A Is BYSI or NBP more profitable? Company Net Margins Return on Equity Return on Assets BeyondSpringN/A N/A -14.00% I-Mab N/A N/A N/A Which has more risk and volatility, BYSI or NBP? BeyondSpring has a beta of 0.41, indicating that its stock price is 59% less volatile than the broader market. Comparatively, I-Mab has a beta of 1.56, indicating that its stock price is 56% more volatile than the broader market. SummaryI-Mab beats BeyondSpring on 8 of the 14 factors compared between the two stocks.How does BeyondSpring compare to Alector?Alector (NASDAQ:ALEC) and BeyondSpring (NASDAQ:BYSI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations. Which has higher valuation & earnings, ALEC or BYSI? BeyondSpring has lower revenue, but higher earnings than Alector. BeyondSpring is trading at a lower price-to-earnings ratio than Alector, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlector$21.05M11.74-$142.93M-$1.19N/ABeyondSpring$1.75M35.25-$1.01M-$0.14N/A Do insiders & institutionals believe in ALEC or BYSI? 85.8% of Alector shares are owned by institutional investors. Comparatively, 40.3% of BeyondSpring shares are owned by institutional investors. 8.3% of Alector shares are owned by company insiders. Comparatively, 29.3% of BeyondSpring shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts recommend ALEC or BYSI? Alector presently has a consensus price target of $3.63, indicating a potential upside of 62.92%. Given Alector's stronger consensus rating and higher probable upside, equities analysts plainly believe Alector is more favorable than BeyondSpring.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alector 2 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.13BeyondSpring 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Does the media favor ALEC or BYSI? In the previous week, BeyondSpring had 4 more articles in the media than Alector. MarketBeat recorded 4 mentions for BeyondSpring and 0 mentions for Alector. BeyondSpring's average media sentiment score of 0.72 beat Alector's score of 0.00 indicating that BeyondSpring is being referred to more favorably in the news media. Company Overall Sentiment Alector Neutral BeyondSpring Positive Is ALEC or BYSI more profitable? BeyondSpring has a net margin of 0.00% compared to Alector's net margin of -680.83%. BeyondSpring's return on equity of 0.00% beat Alector's return on equity.Company Net Margins Return on Equity Return on Assets Alector-680.83% -295.17% -40.95% BeyondSpring N/A N/A -14.00% Which has more risk and volatility, ALEC or BYSI? Alector has a beta of 0.64, suggesting that its stock price is 36% less volatile than the broader market. Comparatively, BeyondSpring has a beta of 0.41, suggesting that its stock price is 59% less volatile than the broader market. SummaryBeyondSpring beats Alector on 9 of the 16 factors compared between the two stocks.How does BeyondSpring compare to Keros Therapeutics?Keros Therapeutics (NASDAQ:KROS) and BeyondSpring (NASDAQ:BYSI) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends. Does the media favor KROS or BYSI? In the previous week, Keros Therapeutics had 7 more articles in the media than BeyondSpring. MarketBeat recorded 11 mentions for Keros Therapeutics and 4 mentions for BeyondSpring. BeyondSpring's average media sentiment score of 0.72 beat Keros Therapeutics' score of -0.07 indicating that BeyondSpring is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Keros Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral BeyondSpring 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, KROS or BYSI? Keros Therapeutics has a beta of 0.95, suggesting that its stock price is 5% less volatile than the broader market. Comparatively, BeyondSpring has a beta of 0.41, suggesting that its stock price is 59% less volatile than the broader market. Which has preferable valuation and earnings, KROS or BYSI? Keros Therapeutics has higher revenue and earnings than BeyondSpring. BeyondSpring is trading at a lower price-to-earnings ratio than Keros Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKeros Therapeutics$244.06M0.91$87.01M-$3.01N/ABeyondSpring$1.75M35.25-$1.01M-$0.14N/A Do insiders and institutionals believe in KROS or BYSI? 71.6% of Keros Therapeutics shares are owned by institutional investors. Comparatively, 40.3% of BeyondSpring shares are owned by institutional investors. 20.6% of Keros Therapeutics shares are owned by insiders. Comparatively, 29.3% of BeyondSpring shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is KROS or BYSI more profitable? BeyondSpring has a net margin of 0.00% compared to Keros Therapeutics' net margin of -256.60%. BeyondSpring's return on equity of 0.00% beat Keros Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Keros Therapeutics-256.60% -17.04% -15.84% BeyondSpring N/A N/A -14.00% Do analysts prefer KROS or BYSI? Keros Therapeutics currently has a consensus target price of $20.40, indicating a potential upside of 82.63%. Given Keros Therapeutics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Keros Therapeutics is more favorable than BeyondSpring.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Keros Therapeutics 1 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.25BeyondSpring 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummaryKeros Therapeutics beats BeyondSpring on 9 of the 16 factors compared between the two stocks.How does BeyondSpring compare to Arcturus Therapeutics?BeyondSpring (NASDAQ:BYSI) and Arcturus Therapeutics (NASDAQ:ARCT) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, dividends, valuation and earnings. Which has better earnings and valuation, BYSI or ARCT? BeyondSpring has higher earnings, but lower revenue than Arcturus Therapeutics. BeyondSpring is trading at a lower price-to-earnings ratio than Arcturus Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeyondSpring$1.75M35.25-$1.01M-$0.14N/AArcturus Therapeutics$42.35M4.81-$65.78M-$2.81N/A Do analysts rate BYSI or ARCT? Arcturus Therapeutics has a consensus price target of $25.44, indicating a potential upside of 255.02%. Given Arcturus Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Arcturus Therapeutics is more favorable than BeyondSpring.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BeyondSpring 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Arcturus Therapeutics 1 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.67 Does the media refer more to BYSI or ARCT? In the previous week, BeyondSpring had 3 more articles in the media than Arcturus Therapeutics. MarketBeat recorded 4 mentions for BeyondSpring and 1 mentions for Arcturus Therapeutics. BeyondSpring's average media sentiment score of 0.72 beat Arcturus Therapeutics' score of -0.22 indicating that BeyondSpring is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BeyondSpring 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Arcturus Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility and risk, BYSI or ARCT? BeyondSpring has a beta of 0.41, indicating that its stock price is 59% less volatile than the broader market. Comparatively, Arcturus Therapeutics has a beta of 2.43, indicating that its stock price is 143% more volatile than the broader market. Is BYSI or ARCT more profitable? BeyondSpring has a net margin of 0.00% compared to Arcturus Therapeutics' net margin of -143.80%. BeyondSpring's return on equity of 0.00% beat Arcturus Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets BeyondSpringN/A N/A -14.00% Arcturus Therapeutics -143.80%-36.55%-28.40% Do institutionals & insiders have more ownership in BYSI or ARCT? 40.3% of BeyondSpring shares are held by institutional investors. Comparatively, 94.5% of Arcturus Therapeutics shares are held by institutional investors. 29.3% of BeyondSpring shares are held by company insiders. Comparatively, 17.8% of Arcturus Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryBeyondSpring beats Arcturus Therapeutics on 9 of the 17 factors compared between the two stocks.How does BeyondSpring compare to Adherex Technologies?Adherex Technologies (NASDAQ:FENC) and BeyondSpring (NASDAQ:BYSI) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, profitability, earnings, analyst recommendations and institutional ownership. Which has preferable earnings and valuation, FENC or BYSI? BeyondSpring has lower revenue, but higher earnings than Adherex Technologies. Adherex Technologies is trading at a lower price-to-earnings ratio than BeyondSpring, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdherex Technologies$44.64M7.66-$9.74M-$0.29N/ABeyondSpring$1.75M35.25-$1.01M-$0.14N/A Does the media prefer FENC or BYSI? In the previous week, Adherex Technologies had 1 more articles in the media than BeyondSpring. MarketBeat recorded 5 mentions for Adherex Technologies and 4 mentions for BeyondSpring. BeyondSpring's average media sentiment score of 0.72 beat Adherex Technologies' score of 0.40 indicating that BeyondSpring is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adherex Technologies 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral BeyondSpring 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders have more ownership in FENC or BYSI? 55.5% of Adherex Technologies shares are owned by institutional investors. Comparatively, 40.3% of BeyondSpring shares are owned by institutional investors. 10.7% of Adherex Technologies shares are owned by company insiders. Comparatively, 29.3% of BeyondSpring shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more risk and volatility, FENC or BYSI? Adherex Technologies has a beta of 0.91, indicating that its stock price is 9% less volatile than the broader market. Comparatively, BeyondSpring has a beta of 0.41, indicating that its stock price is 59% less volatile than the broader market. Is FENC or BYSI more profitable? BeyondSpring has a net margin of 0.00% compared to Adherex Technologies' net margin of -17.12%. BeyondSpring's return on equity of 0.00% beat Adherex Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Adherex Technologies-17.12% -43.87% -11.35% BeyondSpring N/A N/A -14.00% Do analysts prefer FENC or BYSI? Adherex Technologies currently has a consensus target price of $15.40, indicating a potential upside of 55.48%. Given Adherex Technologies' stronger consensus rating and higher probable upside, equities analysts plainly believe Adherex Technologies is more favorable than BeyondSpring.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adherex Technologies 2 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.57BeyondSpring 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummaryAdherex Technologies beats BeyondSpring on 9 of the 17 factors compared between the two stocks. Get BeyondSpring News Delivered to You Automatically Sign up to receive the latest news and ratings for BYSI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BYSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BYSI vs. The Competition ExportMetricBeyondSpringMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$61.68M$3.38B$6.39B$12.33BDividend YieldN/A2.30%2.79%5.33%P/E Ratio-10.7119.0321.0625.70Price / Sales35.25299.85580.1399.36Price / Cash12.67129.8244.1356.16Price / Book-2.036.9810.107.04Net Income-$1.01M$24.45M$3.55B$335.04M7 Day Performance10.29%3.76%4.91%2.69%1 Month Performance-7.98%-0.17%1.57%1.49%1 Year Performance-10.71%62.88%36.63%35.72% BeyondSpring Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BYSIBeyondSpring0.3258 of 5 stars$1.50+4.2%N/A-16.5%$61.68M$1.75MN/A80News CoverageNBPI-Mab3.26 of 5 stars$2.07+0.5%$9.00+334.8%N/A$239.40M$3.89MN/A380ALECAlector3.0838 of 5 stars$2.15-0.5%$3.63+68.6%+76.8%$238.71M$21.05MN/A270KROSKeros Therapeutics2.7074 of 5 stars$11.99+2.9%$20.40+70.1%-20.1%$237.28M$244.06M6.59100News CoverageAnalyst RevisionARCTArcturus Therapeutics2.2553 of 5 stars$8.26+0.1%$25.44+208.0%-42.2%$234.77M$42.35MN/A180 Related Companies and Tools Related Companies NBP Competitors ALEC Competitors KROS Competitors ARCT Competitors FENC Competitors UNCY Competitors MGNX Competitors NKTX Competitors CNTX Competitors CRBP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BYSI) was last updated on 5/22/2026 by MarketBeat.com Staff. From Our PartnersThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?On July 17th, the House passed the GENIUS Act - and at least one prominent Trump ally is raising alarms. Rep. ...Goldco Direct, LLC | SponsoredThe filing was one thing. June 1 is another.The SpaceX filing got attention - but according to macroeconomic strategist Dr. Mark Skousen of The Oxford Clu...The Oxford Club | SponsoredYour book attachedBill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...Profits Run | Sponsored"Computers are about to become obsolete" - George Gilder. Here’s why.George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and ...Eagle Publishing | SponsoredHidden on Tesla's filing: A $12 billion "super startup"Tesla's most recent SEC filing contains a single line showing $12 billion in revenue from a new venture Elon M...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BeyondSpring Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BeyondSpring With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
